Clorox Company 2027 Q1 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Clorox said fiscal year 2027 first-quarter results were better than expected, supported by strong execution and favorable timing benefits.
- Management reported steady progress in organic sales growth, market share and consumption, while noting continued input-cost pressure.
- Home care gained over a half a share point, Brita recorded strong share growth, and Hidden Valley grew almost two share points; Burt’s Bees and Glad trash were about flat.
- Cat litter remained a share drag, while Kingsford delivered high single-digit growth and share growth over Labor Day.
- Health and wellness price mix was about 7 percent, including about 6 points from the Gojo acquisition and about one point from the base business.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good day, ladies and gentlemen, and welcome to The Clorox Company fiscal year 2027 first quarter earnings release conference call. At this time, all participants are in a listen-only mode. At the conclusion of our prepared remarks, we will conduct a question-and-answer session. If you would like to ask a question, you may press star 1 on your touchtone pad at any time. If anyone should require assistance during the conference, please press the star 0 on your touchtone pad at any time. As a reminder, this call is being recorded. I would now like to introduce your host for today's conference call, Ms. Lisah Burhan, Vice President of Investor Relations for The Clorox Company. Ms. Burhan, you may begin your conference.
Thank you, Jen. Good afternoon, everyone, and thank you for joining us. On the call with me today are Linda Rendle, our Chair and CEO, and Luc Bellet, our CFO. Please note that our earnings release and prepared remarks are available on our website at thecloroxcompany.com. Linda will share a few opening comments, then we will take your questions. During this call, we may make forward-looking statements, including about our fiscal year 2027 outlook. These statements are based on management's current expectations, but may differ from actual results or outcomes. In addition, we may refer to certain non-GAAP financial measures. Please refer to the forward-looking statement section, which identifies various factors that could affect such forward-looking statements, which has been filed with the SEC.
In addition, please refer to the non-GAAP financial information section of our earnings release and the supplemental financial schedules in the investor relations section of our website for reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures. I will now turn it over to Linda.
Thanks, Lisah, and thank you for joining us today. We entered fiscal year 2027 focused on steadily improving performance and market share while navigating continued input cost pressures. We made good progress in the first quarter, delivering better-than-expected results through strong execution and some favorable timing benefits. Importantly, the underlying trajectory of the business continues to move in the right direction, with steady progress in organic sales growth and market share. At the same time, we continue to advance the priorities that will strengthen our performance over time. We are improving superiority and innovation across our portfolio, integrating GOJO to unlock the full potential of Clorox Purell ProCare, continuing to evolve our portfolio, and advancing our transformation efforts from a period of significant investment toward one of optimization and value creation. Together, these priorities are focused on building a stronger business that delivers more consistent, profitable growth.
While we are encouraged by the start to the year, we recognize that the operating environment remains challenging and uncertain. Consumers continue to seek value, competitive activity remains elevated, and increased commodity and transportation costs are putting additional pressure on margins. We have a strong track record of managing cost pressures, and we are taking balanced actions to mitigate their impact while continuing to invest in improving our top-line trajectory. The pace of that improvement will be driven in large part by our continued progress on superiority. Our updated outlook reflects these realities, along with the actions we are taking to mitigate their impact. Our focus remains on strengthening brand superiority, improving the consistency of our performance, and creating sustainable value over time. As you saw in our announcement on Thursday, the board has appointed Fabian Garcia as Clorox's next CEO.
Through the process, I have had the opportunity to get to know Fabian, and I have been impressed by both his experience and his perspective on our business. He is an accomplished global consumer products leader with a strong track record of building brands, evolving portfolios, developing talent, and delivering disciplined growth. Between now and January, I remain fully focused on executing our strategy, delivering our commitments, and maintaining momentum while supporting a smooth transition and helping Fabian hit the ground running. With that, we will open the line for questions.
Thank you, Ms. Rendle. Ladies and gentlemen, if you have a question, please press star 1 on your touchtone telephone. Our first question today will come from Peter Grom with UBS.
Great. Thank you. Good afternoon, everyone. Linda, if this is your last earnings call, I just wanted to say thank you for everything and then best wishes moving forward.
Thanks, Peter. It is. I appreciate that.
No, yeah. Thank you, Linda. Maybe just to start, just on the commodity outlook, the commentary in the prepared remarks was very helpful. But just given how volatile the external environment is, can you unpack the underlying assumptions embedded in the updated guidance? Is there anything you can share on the phasing of that cost pressure as we think about the balance of the year?
Sure, I can take that, Peter. As you read in our prepared remark, we now expect input cost inflation for the fiscal year to be about $240 million, and that's about $40 million more than we expected at the beginning of the year. The increase is mainly driven by just the range of commodities as well as transportation costs. For perspective, the $240 million is about two and a half times higher our historical annual average rate. What I would say is, while oil remained an important variable, it's important to recognize that inflation we're dealing with is broader than energy alone, right? We're seeing, on commodities, we're seeing resin being a significant driver, but we're also seeing inflation across a wide range of commodities.
Beyond commodities, we are seeing inflation in broader area of supply chain, including supply, supplier cost increase, as well as transportation and other logistic costs. From an oil standpoint, we're assuming that the Brent annual average price would be around $100. But again, keep in mind that the inflationary pressures are proving much more persistent and extend beyond the oil headline. From a phasing standpoint, we expect inflations will be more pronounced in the first half, and then in the second half. In the second half, we'll also see many of our mitigation actions stacking up and starting ramping up over time. So, that's why you're seeing an imbalance between the front half gross margin and the second half gross margin.
That's really helpful. Then, second, you noted some of the moving pieces around Q2 organic sales, including a shipment comparison and some merchandising and timing dynamics that will push organic sales to be flat to -2%. I know it all depends on where you fall within these ranges, but at first glance, it seems like that would imply a return to growth in the back half of the year to get the flat to up slightly. Maybe first, am I thinking about that the right way? If so, can you maybe unpack what drives the confidence that trends will improve in the back half of the year?
Sure. Maybe let me actually just get us regrounded on the full year, then talk about the phasing over the both halves, and I can briefly touch on the timing for the second quarter. So for the full year, our organic sales growth rate is expected to be three and a half to four and a half, and that includes about 3.5 points of benefit from lapping the ERP transition. So essentially, our guidance is organic sales growth, excluding the impact of the ERP, is flat to +1% for the full year. As you mentioned, from a phasing standpoint, we expect organic sales growth, excluding the ERP, to be down slightly in the front half and up slightly in the back half.
Now, the way to think about it, there's a little bit of noise, especially in the front half, between organic sales growth and consumption, and some of it is driven by the Kingsford trough, some of it is driven by some of the ERP lap. But if you really look at the annual retail consumption, it's essentially flat in the front half and then become up slightly in the back half. As a reminder, last fiscal year, we started in negative low single digits, and so we've been improving sequentially through the front half of this year and continue to improve in the back half of this year. So essentially, while we're not where we want, you can see that the outlook has seen that the business is moving in the right direction, reflecting steady progress on market share and consumption. So that's for the phasing.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
13 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
